Antiemesis

J Natl Compr Canc Netw. 2007 Jan;5(1):12-33. doi: 10.6004/jnccn.2007.0004.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Antiemetics / therapeutic use*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Aprepitant
  • Area Under Curve
  • Clinical Protocols
  • Drug Interactions
  • Humans
  • Medical Oncology / standards
  • Morpholines / adverse effects
  • Morpholines / therapeutic use
  • Nausea / prevention & control
  • Neoplasms / drug therapy
  • Neoplasms / radiotherapy
  • Neurokinin-1 Receptor Antagonists
  • Radiotherapy / adverse effects
  • Serotonin 5-HT3 Receptor Antagonists
  • Vomiting / chemically induced
  • Vomiting / drug therapy*
  • Vomiting / physiopathology
  • Vomiting / prevention & control

Substances

  • Antiemetics
  • Antineoplastic Agents
  • Morpholines
  • Neurokinin-1 Receptor Antagonists
  • Serotonin 5-HT3 Receptor Antagonists
  • Aprepitant